Artificial Intelligence in Life Sciences Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035)

Artificial Intelligence in Life Sciences Market Overview

Artificial Intelligence (AI) in life sciences is transforming research, drug development, and healthcare delivery by enabling advanced data analytics and predictive modeling. The increasing R&D complexity and demand for faster outcomes are accelerating adoption across the sector. AI-driven tools support genomics, clinical research, and precision medicine initiatives. Additionally, the growing use of real-world evidence is enhancing decision-making, improving patient outcomes, and driving innovation across the global life sciences market. The market reached a value of approximately USD 2755.75 Million in 2025.

Artificial Intelligence in Life Sciences Market Growth Drivers

Increasing AI-Enabled Drug Discovery Driving the Market Expansion

Rising demand for faster, cost-efficient drug development and optimized research workflows is propelling market growth. For instance, in January 2026, major life sciences companies, including Lilly and NVIDIA, implemented the BioNeMo AI platform, enhancing predictive modeling and laboratory automation. This adoption supports early-stage drug-target interaction analysis, improving research efficiency and accelerating AI integration across pharmaceutical and biotechnology development globally, driving innovation and operational improvements across the life sciences sector.

Artificial Intelligence in Life Sciences Market Trends

Key trends shaping the market include increasing AI adoption, regulatory advancements, data-driven research expansion, and growing investments accelerating innovation and market growth.

Advancing Regulatory AI Adoption Accelerating the Market Demand

Increasing regulatory complexity and rising demand for efficient compliance processes are key trends shaping market development. For instance, in March 2026, the FDA Group launched AICA, an AI-powered platform designed to automate quality management system audits and streamline compliance workflows. This advancement is expected to accelerate adoption of regulatory AI, enhancing audit efficiency, reducing timelines, and supporting scalable growth across the artificial intelligence in life sciences market.

Artificial Intelligence in Life Sciences Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Artificial Intelligence in Life Sciences Market Share

Cloud Segment Expected to Lead the Market Share by Deployment

The cloud segment dominated the market by deployment, accounting for more than 51% share in the historical period, driven by scalability, cost efficiency, and seamless data integration capabilities. Cloud-based platforms enable real-time analytics and support collaborative research across organizations. The increasing reliance on digital infrastructure is further strengthening data-driven research, enabling enhanced data accessibility, improved decision-making, and accelerated innovation across life sciences research and development activities globally.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global Artificial Intelligence in Life Sciences Market Analysis by Region

North America dominated the market, accounting for approximately 49% share in the historical period, supported by advanced technological infrastructure and strong investment in research. The region benefits from early adoption of AI-driven solutions across healthcare and pharmaceutical sectors. Increasing implementation of AI technologies is enhancing laboratory automation, improving data accuracy, streamlining workflows, and supporting efficient research and development processes across life sciences organizations.

Leading Players in the Artificial Intelligence in Life Sciences Market

Other key players in the market are Nuance Communications Inc., Databricks, IQVIA, SAS Institute Inc., Sorcero, and Indegene.

Key Questions Answered in the Artificial Intelligence in Life Sciences Market Report

• What was the artificial intelligence in Life Sciences market value in 2025?
• What is the artificial intelligence in Life Sciences market forecast outlook for 2026-2035?
• What major factors aid the demand for artificial intelligence in Life Sciences market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major artificial intelligence in Life Sciences market trends?
• Which offering is expected to dominate the market segment?
• Which deployment is projected to lead the market segment?
• Which application is likely to lead the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players in the artificial intelligence in Life Sciences market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?